TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Craig Collard
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors

Heron Therapeutics announced the appointment of Thomas Cusack to its Board of Directors, effective October 27, 2025. Cusack brings over 20 years of investment management and corporate finance experience, most recently serving as a Managing Director at Starboard Value LP.

Insights
DASTY   positive

Listed among leading MES providers, well-positioned for digital manufacturing innovation


HRTX   positive

Company is expanding board expertise with an experienced finance professional, signaling potential strategic improvements